Cochlear Limited (ASX:COH)
258.74
-1.27 (-0.49%)
At close: Feb 5, 2026
Cochlear Revenue
In the fiscal year ending June 30, 2025, Cochlear had annual revenue of 2.34B AUD with 4.81% growth. Cochlear had revenue of 1.17B in the half year ending June 30, 2025, with 11.46% growth.
Revenue
2.34B
Revenue Growth
+4.81%
P/S Ratio
7.22
Revenue / Employee
426.02K
Employees
5,500
Market Cap
16.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 2.34B | 107.50M | 4.81% |
| Jun 30, 2024 | 2.24B | 299.50M | 15.47% |
| Jun 30, 2023 | 1.94B | 287.80M | 17.46% |
| Jun 30, 2022 | 1.65B | 150.70M | 10.06% |
| Jun 30, 2021 | 1.50B | 177.00M | 13.40% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PolyNovo | 128.70M |
| SomnoMed | 111.49M |
| Aroa Biosurgery | 79.26M |
| Compumedics | 51.04M |
| CleanSpace Holdings | 19.76M |
| Lumos Diagnostics Holdings | 18.91M |
| Micro-X | 13.05M |
| 4DMedical | 5.85M |
Cochlear News
- 23 days ago - LARGE CAP INTERNATIONAL PORTFOLIO Buys Shares of Cochlear Ltd (COH) - GuruFocus
- 4 weeks ago - Cochlear Announces Availability of Nucleus Nexa System to US Military Veterans - PRNewsWire
- 2 months ago - MRI 3T Cochlear Implant Market Poised for 9.96% CAGR Growth, North America Leads - GlobeNewsWire
- 2 months ago - Saluda Medical shares sink in worst ASX debut in decades - The Australian Financial Review
- 2 months ago - MED-EL Cochlear Implant Becomes First FDA-Approved Option for Children Seven Months and Older - Business Wire
- 2 months ago - Saluda Medical set for $775m ASX debut - The Australian Financial Review
- 3 months ago - Brokers throw open $125m Epiminder IPO book; Cochlear in for $10m - The Australian Financial Review
- 6 months ago - Cochlear reports FY results - Seeking Alpha